Sort
16,300 grants matching “fatty liver disease”
Mechanisms of Liver Inflammation
$145,973Harmeet Malhi · Mayo Clinic Rochester · K08 · FY2014 · DK
ER-mitochondrial communication in calcium signaling, energy metabolism and liver disease
$145,860Gyorgy Hajnoczky · Thomas Jefferson University · R01 · FY2023 · DK
ER-mitochondrial communication in calcium signaling, energy metabolism and liver disease
$145,860Gyorgy Hajnoczky · Thomas Jefferson University · R01 · FY2022 · DK
The Role of Liver X Receptors (LXRs) in the Pathogenesis of Hepatic Fibrosis
$145,764Simon William Beaven · University Of California Los Angeles · K08 · FY2014 · DK
The Role of Liver X Receptors (LXRs) in the Pathogenesis of Hepatic Fibrosis
$145,764Simon William Beaven · University Of California Los Angeles · K08 · FY2012 · DK
The role of annexin A6 in breast cancer metastasis
$145,666Amos Malle Sakwe · Meharry Medical College · SC2 · FY2012 · CA
The Metabolic Syndrome in Mexican American Children
$145,554Ravindranath Duggirala · Texas Biomedical Research Institute · R01 · FY2009 · HD
A Systemically Deliverable RNAi-based Approach for Alcoholic Liver Disease
$145,500Laura M Hales · Extend Biosciences, Inc. · R43 · FY2014 · AA
Targeting Hepatocyte Senescence to Improve NAFLD
$145,247Kuo Du · Duke University · K01 · FY2024 · DK
Developmental effects of intestinal microbes on metabolic and behavioral circadian rhythms
$145,218Vanessa Anne Leone · University Of Wisconsin-Madison · R21 · FY2024 · DK
Origin and Fate of Myofibroblasts in Alcoholic Liver Disease
$145,215David A Brenner · University Of Southern California · P50 · FY2017 · AA
The role of cell type-specific necroptosis on chronic inflammation and cell non-autonomous effects on other tissues
$145,000Deepa Sathyaseelan · University Of Oklahoma Hlth Sciences Ctr · R01 · FY2022 · AG
Chemoprevention Efficacy of Sulforaphane Against Obesity-Induced Endometrial Carcinogenesis
$145,000Robert S Mannel · University Of Oklahoma Hlth Sciences Ctr · P30 · FY2021 · CA
Cholestasis Prevention: Efficacy of IV Fish Oil
$144,932Mark Puder · Boston Children'S Hospital · R01 · FY2009 · FD
UCSF Liver Center (DDRCC Directors Meeting, Year 2020)
$144,894Jacquelyn J. Maher · University Of California, San Francisco · P30 · FY2019 · DK
CD36 AND HEPATIC STELLATE CELL ACTIVATION
$144,800University Of Kentucky · R21 · FY2001 · AA
CD36 AND HEPATIC STELLATE CELL ACTIVATION
$144,800University Of Kentucky · R21 · FY2002 · AA
Collaborative Clinical Research on Non Alcoholic Stratohepatitis
$144,778Naga P. Chalasani · Indiana University Indianapolis · U01 · FY2010 · DK
HIV: Metabolic Abnormalities
$144,652Rakhi Kohli · Tufts Medical Center · K23 · FY2010 · DK
Project 1 - Disruption of CpG island-mediated gene regulation and chromatin architecture in progeria and aging
$144,606Samuel Beck · Mount Desert Island Biological Lab · P20 · FY2021 · GM
A Mouse Model for Human Inherited Diseases
$144,551Philip A Wood · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2008 · RR
Early Onset Obesity and Cognitive Impairment in Pseudohypoparathyroidism
$144,525Ashley Hall Shoemaker · Vanderbilt University · K23 · FY2014 · DK
EFFECT OF HIGH DOSE VITAMIN E ON CAROTID ATHERSCLEROSIS
$144,500University Of California Davis · R01 · FY2001 · AT
Novel mechanisms and vascular interactions mediating the cardiometabolic benefits of exercise
$144,500Carmen Susana Cavallero · Charles R. Drew University Of Med & Sci · R16 · FY2025 · GM
Impact of inverse relationship between TP53 and CARF on the development of hepatic steatosis and insulin resistance
$144,500Kamrul M Hasan · Charles R. Drew University Of Med & Sci · R16 · FY2024 · GM